U.K. moves forward with three-parent IVF
The country's fertility regulator has approved the first application to carry out mitochondrial replacement therapy, which uses biological material from two women and one man to create an embryo.
Mitochondrial replacement therapy (MRT), also known as three-parent in vitro fertilization, is set to make its way to the clinic in the U.K. Last week (March 16), the country's Human Fertilisation and Embryo Authority (HFEA) approved the first application for license to perform the procedure. The HFEA granted a license to Newcastle University, where researchers have been studying the technique for several years.
"I can confirm today that the HFEA has approved the first application by Newcastle Fertility at Life for the use of mitochondrial donation to treat patients," HFEA Chair Sally Cheshire told CNN. "Patients will now be able to apply individually to the HFEA to undergo mitochondrial donation treatment at Newcastle, which will be life-changing for them, as they seek to avoid passing on serious genetic diseases to future generations."
Source: U.K. moves forward with three-parent IVF